BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10077528)

  • 1. Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis.
    Watson JE; Gabra H; Taylor KJ; Rabiasz GJ; Morrison H; Perry P; Smyth JF; Porteous DJ
    Genome Res; 1999 Mar; 9(3):226-33. PubMed ID: 10077528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
    Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer.
    Lin H; Pizer ES; Morin PJ
    Genomics; 2000 Nov; 69(3):391-4. PubMed ID: 11056057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
    Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of glioblastoma-associated homozygously deleted DNA fragments from chromosomal region 9p21 suggests involvement of multiple tumour suppressor genes.
    Simons A; Jeuken JW; Eleveld MJ; Boerman RH; Geurts Van Kessel A
    J Pathol; 1999 Nov; 189(3):402-9. PubMed ID: 10547603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
    Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells.
    Florl AR; Schulz WA
    Genes Chromosomes Cancer; 2003 Jun; 37(2):141-8. PubMed ID: 12696062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
    Cheng JQ; Jhanwar SC; Lu YY; Testa JR
    Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
    Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
    Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines.
    Kastury K; Baffa R; Druck T; Ohta M; Cotticelli MG; Inoue H; Negrini M; Rugge M; Huang D; Croce CM; Palazzo J; Huebner K
    Cancer Res; 1996 Mar; 56(5):978-83. PubMed ID: 8640789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mapping at 12p12-13 in metastatic prostate cancer.
    Kibel AS; Freije D; Isaacs WB; Bova GS
    Genes Chromosomes Cancer; 1999 Jul; 25(3):270-6. PubMed ID: 10379873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.